8-K ·Filed Apr 13, 2026

PHGE

BiomX Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001213900-26-042811
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▲ Bullish

Monitor shareholder approval process and Israel Innovation Authority regulatory clearance. The integration of DFSL's technology with BiomX's existing Zorronet platform could create synergies in AI-enabled security systems, but execution risk remains.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PHGE ▼ -89.51% at T+60d
LONG call ✗ call lost -89.51% · α vs SPY -98.44% · entry $2.63 → $0.2758
Entry anchored
Apr 10, 03:16 PM ET
via exchange tick
T+1d
-15.97%
call -15.97% · α -17.18%
$2.21
settled 6mo ago
T+5d
-44.49%
call -44.49% · α -47.78%
$1.46
settled 6mo ago
T+20d
-74.30%
call -74.30% · α -82.02%
$0.6760
settled 5mo ago
T+60d
-89.51%
call -89.51% · α -98.44%
$0.2758
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

BiomX Inc. completed the acquisition of DFSL, a defense technology company, using a combination of cash, a convertible note, stock, and warrants. The deal expands BiomX's presence in the defense and security sector with AI-powered detection systems. The transaction is subject to shareholder and regulatory approval.

Key Financial Metrics

Deal Value
$3.8M
Deal Type
acquisition

Key Facts

  • BiomX acquired 60% of DFSL for $750,000 in cash, a $3 million convertible note, 923,000 shares of stock, pre-funded warrants for 923,000 shares, and a five-year warrant for 3,692,000 shares
  • The acquisition strengthens BiomX's position in AI-enabled security systems with DFSL's LADAR-based detection technology
  • The transaction is subject to shareholder approval for issuances exceeding 19.99% of outstanding shares and regulatory approval from the Israel Innovation Authority
  • Mandragola will provide a credit line to support DFSL's development and debt payment
  • A revenue bonus of 5% of annual revenues above $25 million is tied to future performance

Financial Impact

Total deal value of $3.75 million in cash and securities, with potential additional payments based on revenue performance

debtdilutionrevenuestrategic positioning

Risk Factors

  • Failure to obtain shareholder approval for the stock issuances
  • Regulatory delays from the Israel Innovation Authority
  • Integration challenges between DFSL's technology and BiomX's existing platforms

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-042811
Document: ea028529301ex10-1.htm0001213900-26-042811
Document: ea028529301ex4-2.htm0001213900-26-042811
Document: ea0285293-8k_biomx.htm0001213900-26-042811
Document: ea028529301ex4-1.htm0001213900-26-042811
Document: ea028529301ex99-1.htm0001213900-26-042811
Document: 0001213900-26-042811-index-headers.html0001213900-26-042811
Document: 0001213900-26-042811-index.html0001213900-26-042811
Document: 0001213900-26-042811.txt0001213900-26-042811
20 reports for PHGE
Performance horizon
70% Hit rate 7 of 10 directional calls best @ T+20▲ +62.36%Jun 16, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access